MedPath

Treatment of donor sites using a non cultured autologous cell suspension: A randomized controlled trial

Not Applicable
Conditions
people who had donor site after skin grafted
Registration Number
JPRN-UMIN000015000
Lead Sponsor
Zhu Jia-Yuan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria consisted in the presence of pre-existing local and systemic bacterial infections, pre-existing medical conditions that would interfere with wound healing (diabetes, malignancy, autoimmune disease), renal failure (glomerular filtration rate inferior to 60 ml/min), medications that could interfere with wound healing (corticosteroids), hypersensitivity to Trypsin or Hartmann's solution, a high anesthesiology risk that necessarily postponed surgery.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath